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Summary 
Major histocompatlbllity complex class II molecules 
bind and present to T cells fragments of protein anti- 
gens entering the endocytic pathway. Using normal 
B lymphoblasts, we have combined metabolic pulse- 
chase labeling, high resolution organelle fractionation, 
and immunopreclpitation to examine class II traffick- 
ing and antigen loading in a physiological model sys- 
tem. Most newly synthesized class II-invariant chain 
complexes first entered early endosomes, then ac- 
cessed multiple discrete endocytic subcompartments 
cofractionating with late endosomes and immature ly- 
sosomes. Invariant chain was removed and peptide- 
loaded class II molecules appeared in each of these 
latter distinct organelles. These findings suggest that 
class II molecules traffic through much of the endo- 
cytic pathway, permitting capture of distinct determi- 
nants made available under differing conditions of pH 
and proteolytic activity. 
Introduction 
The a8 receptor-bearing subset of T lymphocytes is re- 
cruited for host defense by recognition of peptide frag- 
ments associated with cell surface major histocompati- 
bility complex (MHC) class I or class II glycoproteins 
(Germain, 1994). This form of immune recognition appears 
initially to have evolved to permit the adaptive immune 
system to respond to intracellular pathogens that would 
otherwise be protected from recognition by membrane- 
bound receptors. To deal with the distinct intracellular 
compartments inhabited by different pathogens, two 
classes of MHC peptide-binding proteins have developed. 
Class I molecules are responsible for presentation of anti- 
gens found in the cytosol. Class II molecules focus on 
antigens derived primarily from organisms that reside in 
intracellularvesiclesand, as a later adaptation, on proteins 
in theexternal environment that can beselectivelyconcen- 
trated in such compartments by the antigen-specific immu- 
noglobulin receptors of B lymphocytes. 
This view of MHC class II function is consistent with 
direct experimental evidence that the endocytic pathway 
is involved in class Ii-dependent antigen presentation to 
CD4+ T lymphocytes (Brodsky and Guagliardi, 1991; Ger- 
main and Margulies, 1993; Germain, 1994). Following syn- 
thesis, MHC class II dimers associated with invariant chain 
(Ii) are transported from the endoplasmic reticulum (ER) 
through the Golgi complex and the trans-Golgi network 
(TGN) to the endocytic pathway (Neefjes et al., 1990; Pe- 
ters et al., 1991). Ii-free MHC class II dimers containing 
peptide antigen then take 2-3 hr to appear in large 
amounts on the cell surface, passing through one or more 
endocytic compartments prior to movement to the plasma 
membrane. During transport through the endocytic path- 
way, Ii is removed from class II molecules by the action 
of low pH and acid proteases (Nowell and Quaranta, 1985; 
Blum and Cresswell, 1988). This dissociation of Ii, which 
may occur at the same site(s) as antigen degradation, is 
necessary for the binding of antigenic peptides to class 
II molecules (Roche and Cresswell, 1990; Teyton et al., 
1990; Romagnoli and Germain, 1994). In accord with this 
scheme, sequence analysis of peptides eluted from class 
II molecules has identified most of them as derived from 
proteins that can readily access the endocytic pathway 
(Rudensky et al., 1991, 1992; Chicz et al., 1992; Hunt et 
al., 1992). Targeting antigens to endocytic compartments 
significantly increases the efficiency of antigen presenta- 
tion (Snider and Segal, 1987; Casten et al., 1988; Niebling 
and Pierce, 1993) endocytic vesicles contain MHC class 
II-peptide complexes capable of stimulating T cells in a 
presentation assay (Harding and Geuze, 1993; Qiu et al., 
1994) and lysosomotropic agents inhibit the peptide load- 
ing of class II molecules (Harding and Unanue, 1990; Ger- 
main and Hendrix, 1991), as well as their expression on 
the cell surface (Neefjes and Ploegh, 1992; Loss and Sant, 
1993). 
Although these studies have led to general agreement 
on the endocytic pathway as the site of peptide-class II 
interaction, there iscontinuing controversy concerning the 
details of endosomal involvement in antigen processing 
and intracellular peptide binding by class II molecules. At 
least three major organelles populate the endocytic path- 
way: early endosomes, late endosomes, and lysosomes 
(Mellman, 1990). Early endosomes contain a specialized 
sorting subcompartment, and many cells may possess a 
set of vesicles intermediate in character between late en- 
dosomes and dense terminal lysosomes. There is, at pres- 
ent, no consensus on the distribution of class II and Ii 
among these different endocytic subcompartments, on the 
route(s) followed by class II molecules to and from any 
of these distinguishable organelles, on whether peptide 
loading occurs at only one or at multiple sites in this path- 
way, or even on whether these classically described or- 
ganelles are the actual sites of class II trafficking or accu- 
mulation (Germain, 1994). 
Several groups have utilized immunoelectronmicros- 
copy as a tool to address these issues. Guagliardi et al. 
(1990) reported that in an Epstein-Barr virus (EBV)- 
transformed human lymphoblastoid cell line, MHC class 
II molecules, Ii, and internalized immunoglobulin (antigen) 
could be colocalized in early endosomes, suggesting that 
the export route of class II and uptake route of antigen 
meet in this location, and that antigen processing and pep- 
tide binding might occur here. In another study using a 
similar technical approach, class II molecules were in- 
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stead found primarily localized to a prelysosomal compart- 
ment (MIIC) in which Ii was not detected (Peters et al., 
1991). These latter investigators suggested that newly 
synthesized class II molecules do not access all the endo- 
cytic pathway, but are directly transported from the TGN 
to this (late) MIIC compartment (Neefjes et al., 1990), 
where they accumulate and are loaded with peptides. A 
similar predominant localization of class II in lysosome- 
related vesicles was reported in electron microscope stud- 
ies of mouse macrophages (Harding and,Geuze, 1992, 
1993). 
Analysis of COS cells transiently expressing class II mol- 
ecules and Ii, however, revealed substantial levels of a8li 
complexes in both early endosomes and late endosomes/ 
prelysosomes; in the former, Ii was largely intact, whereas 
in the latter, Ii was partially cleaved in its lumenal region 
(Romagnoli et al., 1993). These data were interpreted to 
indicate that early endosomes were the first compartment 
of the endocytic pathway reached by newly synthesized 
a8li complexes, from which they moved to later endocytic 
compartments concomitant with proteolytic degradation of 
Ii and increasing availability of the class II peptide binding 
sites. In accord with this hypothesis, transferrin-neur- 
aminidase conjugates quantitatively desialate newly syn- 
thesized post-Golgi afili complexes (Cresswell, 1985). a/Yi 
complexes have also been detected on the plasma mem- 
brane of EBV-transformed B cell lines. These complexes 
are rapidly internalized, indicating that newly synthesized 
a8li complexes can enter the endocytic pathway from the 
cell surface via early endosomes (Roche et al., 1993). 
Other studies in nonhematopoietic cells (L cells, mela- 
noma cells, and rat-2 fibroblasts) have also shown class 
II and Ii in various parts of the endocytic pathway (Sala- 
mero et al., 1990; Pieters et al., 1991; Simonsen et al., 
1993). 
More recently, several groups using cell fractionation 
methods have described the accumulation of newly syn- 
thesized class II molecules in endocytic vesicles ap- 
pearing to be distinct from typical early endosomes, late 
endosomes, or dense lysosomes (Amigorena et al., 1994; 
Qiuet al., 1994; Tulpet al., 1994; West et al., 1994; Ruden- 
sky et al., 1994). These vesicles were also a site of accu- 
mulation of peptide-loaded class II dimers prior to their 
appearance on the plasma membrane. Such data have 
led to the suggestion of a unique endocytic site for antigen 
processing and intracellular association of peptides with 
MHC class II molecules. Strikingly, however, although 
these various studies reported differences in the proper- 
ties of a class II-rich vesicular compartment compared 
with those of the classically defined endocytic organelles, 
the specific characteristics of the class II-containing vesi- 
cles varied significantly among these studies. In the case 
of the mouse A20 B cell tumor, the compartment seemed 
located early in the endocytic pathway, with the presence 
of some transferrin and rapid access to endocytosed trac- 
ers, but an absence of late endosomal or lysosomal mark- 
ers (Amigorena et al., 1994). In contrast, in melanoma cells 
and human B lymphoblastoid cells, substantial amounts 
of the lysosomal marker lamp-l, an absence of earlyendo- 
somal markers, and, for the latter cells, delayed access 
to endocytosed markers was observed (Qiu et al., 1994; 
Tulp et al., 1994; West et al., 1994). 
The divergent nature of these results thus leaves open 
the question of whether class II molecules traffic to and 
undergo antigen loading in a single specialized compart- 
ment, or whether they move to and through multiple endo- 
cytic organelles, whose relationship to classically defined 
organelles is unclear (Schmid and Jackson, 1994). Be- 
cause many of these studies have employed clonal popu- 
lationsof transformed or transfected cells, the varying find- 
ings may be explained by differentiation-related or even 
cell line-specific differences. The use of antibody re- 
agents with incomplete recognition of Ii-associated versus 
Ii-free MHC class II molecules, as well the resolution and 
sensitivity of the techniques used to fractionate organelles 
or localize MHC molecules may have also contributed to 
this outcome. Here, we have used a combination of subcel- 
lular fractionation and immunoprecipitation to follow over 
time both the distribution of the total cohort of newly syn- 
thesized a3li complexes and the appearance of exoge- 
nous antigen-dependent peptide-loaded class II dimers 
in a physiologic antigen-presenting cell population of B 
lymphoblasts. Thisanalysis reveals the movement of class 
II molecules through, and their transient accumulation in, 
multiple distinguishable endocytic organelles. These data 
further suggest the possibility that peptide loading is not 
a function limited to just one of these organelles, but rather 
is an activity that occurs to varying degrees throughout this 
complex post-TGN itinerary of MHC class II molecules. 
Results 
To provide a comprehensive picture of the intracellular 
itinerary followed by MHC class II molecules and invariant 
chain, and to identify endocytic compartments in which 
class II association .with antigenic peptides takes place, 
it was necessary to identify both the intracellular localiza- 
tion of class II and Ii at various times after synthesis and 
the peptide occupancy state of the class II molecules. En- 
docytic pathway organelles have classically been distin- 
guished in cell fractionation studies on the basis of their 
density, content of marker proteins, and time of access 
to exogenous tracers (Gruenberg and Howell, 1989). To 
carry out a subcellular localization study using a physiolog- 
ically active antigen-presenting cell type, we established 
a method for separation of B lymphoblast intracellular or- 
ganelles by sequential density fractionation. For the detec- 
tion of peptide-loaded molecules, we took advantage of 
the observation that many peptide-occupied MHC class 
II molecules adopt a conformational state that is stable 
during SDS-PAGE under partial denaturing conditions 
(Davidson et al., 1991; Germain and Hendrix, 1991; Sa- 
degh-Nasseri and Germain, 1991) and, in particular, that 
hen egg lysosome (HEL) exposure results in the enhanced 
formation of such SDS-stable dimers among the AakAPk 
molecules synthesized by B cells (Germain and Hendrix, 
1991). By combining the fractionation methodology with 
pulse-chase labeling, immunoprecipitation, and SDS- 
PAGE, we could follow both the route of transport of class 
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Figure 1. Sequential Percoll Gradient Fractionation of B Lymphoblast 
Organelles and Membranes 
(A) Distribution of the endocytic marker B-hexosaminidase (closed cir- 
cle) after fractionation on a 27% Percoll gradient. Fraction 1 corre- 
sponds to the bottom of the gradient. 
(B) Distribution of the endocytic marker f3-hexosaminidase (closed cir- 
cle) and the late Golgi marker galactosyl transferase (open diamond) 
after separation on a lCt% Percoll gradient of the contents of fractions 
corresponding to the light f3-hexosaminidase peak in the 27% gradient. 
II molecules and the site(s) where peptide-loaded class II 
dimers appeared. 
Resolution of Three Distinct Classes of 
Endocytic Pathway Organeiles by 
Sequential Density Fractionation 
Initial fractionation experiments using a widely employed 
27% Percoll gradient method revealed two discrete peaks 
of the endocytic marker enzyme 8-hexosaminidase; a high 
density Peak 1 and a light density Peak 2 (Figure 1A). 
Peak 1 contains what appears to be a mixture of immature 
and mature lysosomes, based on its high density (1 .Og g/ 
ml), the presence of 70% of the total f3-hexosaminidase 
activity, its substantial levels of lamp-l and cathepsin D, 
and the absence of any detectable nonlysosomal markers 
(Figure 2; Table 1). Peak 2 contains activities indicating 
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Figure 2. Distribution of Marker Proteins and Endocytosed Tracers 
in the Fractions of B Lymphoblast Organelles and Membranes Sepa- 
rated on a 27% Percoll Gradient 
the presence of endopiasmic reticulum (BIP), Golgi (gaiac- 
tosyl transferase), TGN38, plasma membrane (Na+ K+ 
ATPase and anti-MHC class II antibody bound at 4%) and 
endosomes (8-hexosaminidase, transferrin) (Figure 2). 
The nature of the organelles contained in the various 
fractions was further examined by kinetic labeling with 
endocytic tracers. in these experiments, B lymphobiasts 
were incubated with ovalbumin at 37% for different 
lengths of time, washed, disrupted, and the ovaibumin 
content determined for each fraction recovered from a 
27% percent gradient. Ovalbumin was detectable in light 
Peak 2 after 20 min of internalization, whereas this tracer 
was only found in high density Peak 1 after 30 min of 
continuous labeling (Figure 2). identical results were also 
obtained when horseradish peroxidase (HRP) was used 
(data not shown). The lack of Cl-MBPR in Peak 1 fractions 
indicates an absence of classical late endosomes, 
whereas the ability of endocytic tracers to access the or- 
ganelles localizing in this peak in only 30 min suggests 
the presence of immature or preiysosomes, in addition to 
dense terminal lysosomes. Thus, a 27% gradient similar 
to that employed by several investigators (Harding and 
Geuze, 1993; Qiu et al., 1994; West et al., 1994) adequately 
separates lysosomal compartments from other endocytic 
pathway organelles, but it does not suitably separate early 
(transferrin-positive) from late (transferrin-negative, Ci- 
MGPR-positive) endosomes, or these endocytic compart- 
ments from components of the secretory pathway or 
plasma membrane. 
To achieve greater resolution of subcellular organeiles, 
especially those of the endocytic pathway, fractions from 
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Table 1. Summary of the Density, Marker Distribution, and Putative Organelle Contents of Peaks 1, 2A, and 28 Recovered from Sequential 
27% and 100/O Percoll Gradient Fractionation of Disrupted S Lymphoblasts 
Subcellular Markers 
Peaks Density (g/ml) p-hex GT TGN-36 Tf lamp-l cath. D PM-IS MGPR SIP Characterization 
Peak 1 high (- 1.06) +++ - - 
Peak 2A intermediate.( - 1.05) + - - 
Peak 28 light (- 1.03) + + + 
- + ++ - - Lysosomes, mitochondria 
- f + + - Late endosomes 
+ + + + + + W, Golgi, TGN, early 
endosomes, plasma 
membrane 
B-hex, 6-hexosaminidase; GT, galactosyl transferase; Tf, transferrin; cath. D, cathepsin D; PM-Ig, surface membrane bound immunoglobulin; 
MGPR, mannose+phosphate receptor. 
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Figure 3. Distribution of Marker Proteins and Endocytosed Tracers 
in the Fractions of S Lymphoblast Organelles and Membranes Sepa- 
rated on a 10% Percoll Gradient 
the 27% gradient representing the lighter b-hexosamini- 
dase peak (Peak 2) were pooled and refractionated on 
various less dense Percoll preparations. Use of a 10% 
Percoll gradient gave rise to two well-separated P-hexosa- 
minidase peaks, 2A and 26 (see Figure 1 B). Peak 2A had 
intermediate density(l.05 g/ml), retained 10%-l 5% of the 
total 6-hexosaminidase activity, was positive for Cl-MGPR, 
slightly positive for cathepsin D, and very weak or negative 
for lamp-l (Figure 3; Table 1). In addition, this peak lacked 
markers characteristic of early endosomes, plasma mem- 
brane, endoplasmic reticulum, Golgi, or TGN. The light 
density Peak 28 (1.03 g/ml) possessed markers consistent 
with the presence of Golgi (galactosyl transferase), 
TGN36, early endosomes (transferrin), and plasma mem- 
brane (Na+K+ ATPase and surface bound anti-class II anti- 
body) (Figure 3). It also had low but detectable levels of 
lamp-l and Cl-MGPR, both of which are present as newly 
synthesized proteins in the ER and Golgi, and which have 
been found in minor amounts in early endosomes and on 
plasma membranes in other studies (Harter and Mellman, 
1992; Kornfeld, 1992). The kinetics of labeling of these 
refractionated organelles with endocytic tracers were in 
agreement with the distribution of these markers. Cval- 
bumin (Figure 3) or HRP (data not shown) could be found 
in Peak 2B after just 10 min of internalization. In contrast, 
Peak 2A was not reached by endocytic tracers at 10 min, 
but was accessed after 20 min of such labeling (Figure 
3). This latter result also distinguished the organelles of 
this peak from those in Peak 1 of the 27% gradient, which 
required 30 min to acquire OVA. 
Thus, a combination of two sequential Percoll density 
gradients permitted the separation of three distinct popula- 
tions of endocytic organelles with the markers and tracer 
access characteristics of early endosomes (Peak 28) late 
endosomes (Peak 2A), and lysosomes (Peak 1) (Table 1). 
The fractions containing early endosomal markers over- 
lapped in part fractions with markers of secretory pathway 
organelles (ER, Golgi, TGN) and plasma membrane. 
There was, however, an enrichment of plasma membrane 
markers in the lightest fractions of this peak, and of trans- 
ferrin-rich fractions in the denser portion (Figure 3), which 
allowed some limited conclusions to be drawn about pro- 
teins in these two compartments. 
Steady-State Distribution of MHC 
Class II Heterodimers 
The steady-state distribution of intact unlabeled MHC 
class II heterodimers in B lymphoblasts was assessed by 
solubilizing the membranes from each fraction of the 27% 
and 10% Percoll gradients in NP-40, immunoprecipitating 
the AakAPk molecules using 10-2.16 (a monoclonal anti- 
body [MAb] specificfortheAPkchain), and immunoblotting 
the proteins after SDS-PAGE using rabbit antiserum to 
the cytoplasmic tail of Aa. Significant amounts of MHC 
class II (- 10% of total) were found in the fractions of high 
density Peak 1 (Figure 4A). As expected, most of the class 
II (- 90%) was found in the light membrane Peak 2 of the 
27% gradient, which contains both ER and PM (Figure 
4A). When refractionated on a second gradient, 10% of the 
Peak 2 class II molecules could be specifically localized to 
the late endosome-containing fractions in Peak 2A. The 
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Figure.4. Steady-State Distribution of MHC Class II Molecules 
(A) Location and amount of f3-hexosaminidase and class II Aa chain 
in B lymphoblast organelles and membranes separated on a 27% 
Percoll gradient. The upper portion shows the Aa signal obtained by 
Western blot of material immunoprecipitated with the anti-Af3 antibody 
10-2.16 from solubilized material in the gradient fractions. The lower 
portion quantitates the Aa results and shows the 6-hexosaminidase 
content of the same fractions. 
(B) Location and amount of f3-hexosaminidase and class II Aa chain 
in B lymphoblast organelles and membranes separated on a 10% 
Percoll gradient. The upper portion shows the Aa signal obtained by 
Western blot of material immunoprecipitated with the anti-A6 antibody 
10-2.16 from solubilized material in the gradient fractions. The lower 
portion quantitates the Aa results and shows the 6-hexosaminidase 
content of the same fractions. 
remainder was present in the lighter Peak 2B, which con- 
tains endoplasmic reticulum and plasma membrane, in 
addition to Golgi, TGN, and early endosomes (Figure 48). 
Some class II was in the denser fractions in this peak that 
are enriched in early endosomes, but the bulk was in the 
lightest fractions in which plasma membrane is concen- 
trated. These findings indicate that in B lymphoblasts, sig- 
nificant steady-state amounts of MHC class II are present 
in organelles cofractionating with early endosomes, late 
endosomes, and immature lysosomes, although most 
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Figure 5. Intracellular Distribution of MHC Class II (Aa”A63 and Asso- 
ciated Invariant Chain Immediately after 40 min of Metabolic Labeling 
(A) Distribution throughout the gradient, showing the fractions of the 
27% gradient not subject to refractionation, and the entire 10% gra- 
dient. 
(B) Details of the content of the class II-enriched fractions of the 10% 
gradient. The positions of the individual class II a and 6 chains and 
the Ii p31 and Ii p41 chains are indicated on the left. Molecular weight 
(MW) markers are on the right. For both (A) and (B), adjacent fractions, 
indicated below the autoradiographs, were pooled before immunopre- 
cipitation with an anti-class II MAb, and one half of the resulting precipi- 
tate run without sample heating, the other after boiling (lanes marked 
with an asterisk). 
class II is found on the plasma membrane or associated 
with the ER. 
Distribution of MHC Class II and Ii Molecules at 
Various Times atter Synthesis 
Kinetic Analysis of MHC Class II Distribution 
To relate these steady-state results to the movement of 
class II molecules through the cell after synthesis, and to 
help trace the pathway taken by newly synthesized class 
II-Ii complexes from the secretory pathway to the endo- 
cytic pathway, we analyzed the various gradient fractions 
for radioactive class II molecules at different times after 
metabolic pulse labeling. Precipitation from total cell ly- 
sates immediately after pulse-labeling or after 3-4 hr of 
chase showed that under the conditions used, at least 
85%-90% of all initially labeled class II molecules could 
be precipitated at late chase points (data not shown). This 
relatively constant total level of immunoprecipitable class 
II throughout the chase period permitted meaningful com- 
parisons to be made between independent experiments 
involving different chase times with respect to the distribu- 
tion of class II among different compartments. 
Forty minutes of labeling without a chase period 
After 40 min of metabolic labeling, MHC class II molecules 
were almost all localized to Peak 28 in the form of af3li 
complexes (Figures 5A and 5B), consistent with the pres- 
ence of these molecules in the ER and Golgi complex at 
this early time after initial synthesis. The migration pattern 
of these proteins corresponded to that previously de- 
scribed for AakApk chains with endoglycosidase H-sensi- 
tive N-linked glycans (Germain and Rinker, 1993) consis- 
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tent with a substantial number of the complexes still being 
present in premedial Golgi sites. 
Twenty minutes of chase 
After40 min of metabolic labeling and either20 min (Figure 
6A) or 30 min (data not shown) of chase in the presence 
of the protein antigen source HEL, all three P-hexosamini- 
dase-rich peaks contained labeled MHC class II and Ii. 
As seen in the Western blot analysis of steady-state class 
II, the distribution of newly synthesized class II coincided 
with that of P-hexosaminidase. Densitometric analysis re- 
vealed that Peak 26 (light membranes) contained nearly 
70% of the total immunoprecipitable class II molecules 
at this timepoint, primarily in the form of abli complexes 
(Figure SB). A significant fraction of the class II chains in 
these complexes had mobilities corresponding to chains 
with endoglycosidase H-resistant N-linked glycans (Ger- 
main and Rinker, 1993) indicating passage through the 
medial Golgi. Whether they still resided in the TGN or were 
associated with plasma membrane or early endosomes, 
however, could not be determined from this analysis 
alone. The remaining class II molecules were distributed 
between the other two peaks, with slightly (but consis- 
tently) more in the intermediate density Peak 2A than in 
the dense Peak 1 (Figure 7). 
One hour of chase 
At 1 hr of chase, newly synthesized MHC class II mole- 
cules were still detected in all three peaks (Figures 8A and 
Figure 6. Intracellular Distribution of MHC 
Class II and Associated Ii after 40 min of Meta- 
bolic Labeling and 20 min of Chase 
Methods and labeling are as for Figure 5. 
Figure 7. Summary of the Distribution of Class II and Ii over Time after 
Synthesis among the Various Fractionated Organelles/Membranes of 
B Lymphoblasts 
Total cell, sum of all MHC class II or Ii p31 signals for all fractions 
from both gradients; sum of all MHC class II or Ii signals in the fractions 
comprising a given peak from either the 27% or 10% gradient; com- 
pact, SDS-stable dimers sensitive to heating. 
88). At this time, the relative amount of class II contained 
in the intermediate density Peak 2A was similar to that 
detected at earlier timepoints, suggesting an equilibrium 
state between labeled incoming and outgoing molecules 
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(see Figure 7; Figure 9A). In contrast, the relative amount 
of class II precipitated from the lysosome-rich Peak 1 in- 
creased 2.5-fold compared with the earlier chase point 
(see Figure 7; Figure 9A), suggesting continued entry of 
class II without a concomitantly rapid egress. 
Two hours of chase 
At 2 hr of chase (Figure lo), labeled class II molecules 
were again present in all three peaks. Compared with the 
previous timepoint (1 hr chase), however, there was a 
marked decrease in the relative content of MHC class II 
in the intermediate density Peak 2A (see Figure 7) com- 
patible with a reduction in the flow of incoming labeled 
class II molecules, but continued egress. At this same 
timepoint, Peak 1 contained a similar amount of class II 
to that present at 1 hr of chase (see Figure 7). Thus, the 
relative class II content of intermediate density organelles 
was decreasing at the same time as the dense organelles 
showed a plateau of class II content (see Figure 9A). 
Three hours of chase 
After 3 hr of chase, little class II signal was observed in 
either the dense or intermediate peaks, with almost all the 
class II appearing in a few fractions coincident with the 
plasma membrane marker (data not shown), indicating 
that virtually all of the labeled cohort of class II had reached 
the cell surface. 
Figure 8. Intracellular Distribution of MHC 
Class II and Associated Ii after 40 min of Meta- 
bolic Labeling and 1 hr of Chase 
Methods and labeling are as for Figure 5, ex- 
cept for the addiiional label of C. representing 
the position of peptide-loaded SDS-stable com- 
pact class II dimers. 
Trafficking of MHC Class II-Ii Complexes 
through Early Endosomes 
Two different nonmutually exclusive pathways for traffick- 
ing of class II-Ii complexes to endocytic organelles sharing 
characteristics with late endosomes/immature lysosomes 
have been proposed. One involves movement (possibly 
via the cell surface) to early endosomes, followed by trans- 
port to later endocytic stations (Cresswell, 1985; Guagli- 
ardi et al., 1990; Romagnoli et al., 1993; Roche et al., 
1993); the other involves direct movement of the class II- 
Ii oligomers to late endosomes/lysosomes from the TGN, 
without passage to the plasma membrane or through early 
endosomes (Neefjes et al., 1990; Peters et al., 1991). The 
similar densities of the different organelles in light Peak 
28 (ER, Golgi, TGN, early endosomes, and plasma mem- 
brane) did not permit a direct determination of which or- 
ganelle(s) contained the MHC class II and Ii detected at 
early times of chase. If a substantial amount of the class 
II and Ii were in endocytic compartments rapidly accessed 
by soluble proteins, this would argue for the former model. 
Conversely, if this material was only in the TGN compo- 
nent of Peak 2B, at a time when some class II-Ii complexes 
had already reached dense compartments, this would sup- 
port the latter model. 
To examine what proportion of the class II-Ii complexes 
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Figure 9. Changes in Class II Distribution and Extent of Ii Degradation 
in Various Compartments over Time 
(A) Class II content of intermediate density Peak 2A and of dense 
Peak 1. 
(B) Ratio of MHC class II a chain to intact invariant chain p31 chain 
in various compartments. An increasing ratio indicates progressive 
loss of Ii relative to total class II content in the compartment. No intact 
Ii p31 was detected in Peak 2A at 190 min and no data are plotted 
for this point. 
detectable in the light density peak at early times of chase 
were localized in Golgi or TGN as compared with early 
endosomes and the plasma membrane, we attempted to 
eliminate selectively the signal derived from the latter com- 
partments. For this purpose, cells were labeled for 40 min 
and chased for 30 min. During the last 10 min of chase, the 
cells were cultured in the presence of HRP, then disrupted 
and the resultant membrane preparation applied to a27% 
Percoll gradient. Each collected fraction was then divided 
in two and one aliquot treated with diaminobenzidine 
(DAB) alone, the other with DAB and H202. The polymer- 
ization of DAB causes an increase in organelle density. 
Therefore, HRP-associated organelles, such as the 
plasma membrane and the early endosomes, would be 
expected to shift to a heavier position in the second (10%) 
separation gradient (Courtoy et al., 1984). Consistent with 
this expectation, DAB-H202 treatment resulted in the spe- 
cific loss of both transferrin (data not shown) and 8-hexosa- 
minidase from their original positions in the light mem- 
brane Peak 28, without any change in the distribution of 
galactosyl transferase and TGN38 (Figures 11A and 11 B). 
The distribution of the markers in Peak 2A (which takes 
20 min to be accessed by tracer material) was also not 
affected. This indicates that early endosomes and the 
plasma membrane were specifically altered by this proce- 
dure, whereas the Golgi, the TGN, and late endosomes 
were not affected. DAB-H202 treatment caused a 75% 
decrease in the amount of class II precipitable from Peak 
28 (Figures 11 C and 11 D); many of the residual molecules 
had SDS-PAGE mobility characteristic of proteins with 
immature N-linked glycans, indicating that they still re- 
sided in a premedial Golgi compartment. Because approx- 
imately 70% of all class II is in the light Peak 28 at 30 
min of chase, these data indicate that at least half of the 
newly synthesized a8li complexes are in early endo- 
somes, on plasma membrane, or both shortly after exit 
from the TGN. 
Ii DistrlbutiQn over Time 
After a brief chase (20 min), three quarters of the class 
II-associated Ii p31 was detected in the light membrane 
Peak 28, with much less in Peaks 2A and 1, thus generally 
paralleling the distribution of class II in these locations. 
This suggests that only a small proportion of the invariant 
chain had been proteolyzed or removed from class II at 
this early time after egress from the secretory pathway. 
Nevertheless, compared with material analyzed immedi- 
ately after pulse labeling, there was a measurable relative 
loss of Ii p31 signal compared with class II a chain signal 
in Peak 1 and slightly more so in Peak 2A, indicating that 
Ii removal was already proceeding in these denser endo- 
cytic compartments (see Figure 98). Like class II, most 
of the Ii in light Peak 28 at 20 min of chase was density 
shifted upon DAB-H202 treatment following 10 min of HRP 
uptake (Figures 11 C and 11 D), consistent with the conclu- 
sion that newly synthesized class II and Ii travel to this 
site together. 
At 1 hr of chase, a substantial amount of the class II- 
associated Ii had been degraded and the remaining Ii 
showed a different relative distribution among the peaks. 
The proportion in Peak 28 decreased, while increasing in 
Peaks 2A and 1 (see Figure 7). Increasing amounts of Ii 
fragments were seen upon direct precipitation with anti-Ii 
tail-specific antibody in the latter two compartments (data 
not shown), as also seen by Marie et al. (1994). Because 
most of the class II cohort at this time had a mobility re- 
flecting the presence of mature N-linked glycans, this im- 
plies movement of Ii-associated class II from plasma mem- 
brane, early endosomes, and possibly TGN, to denser 
endocytic compartments during 20-60 min of chase, with 
continuing degradation upon arrival in these latter com- 
partments. By 2 hr of chase, the total amount of intact 
Ii chain coprecipitated with the a8 complex was greatly 
reduced (see Figure 7; Figure 98; Figure lo), consistent 
with the expected extent of proteolysis and dissociation 
of Ii from class II over this time interval (Sung and Jones, 
1981; Blum and Cresswell, 1988; Cresswell et al., 1990). 
Some residual intact Ii p31 was found in dense Peak 1 at 
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this late time, even though the great majority of class II 
dimers in thiscompartment were not associated with intact 
Ii (see Figure 96). This would be anticipated if Ii was de- 
graded rapidly after arrival, but some class II-Ii complexes 
had only just reached this location, either from less dense 
endocytic compartments, or possibly the TGN. 
Small amounts of intact Ii chain p41 (Koch et al., 1987) 
(8%-7% of the total precipitated Ii chain) were also copre- 
cipitated with class II molecules in all three peaks at the 
various chase times. The ratio between p31 and p41 was 
constant among the different intracellular compartments 
at all timepoints examined. 
Appearance of Peptide-Loaded MHC Class II Dimers 
in Multiple Endocytic Organelles and 
on the Plasma Membrane 
The preceding experiments revealed class II in a variety 
of endocytic compartments in 6 lymphoblasts, at least in 
large part as a result of progressive movement from organ- 
elles cofractionating with typical early endosomes, to 
those colocalizing with late endosomes and immature ly- 
sosomes. Ii accompanied class II throughout this traffick- 
ing, and was removed from class II in varying proportions 
and with varying kinetics in the different locations. To re- 
late this pattern of movement and Ii removal to peptide 
loading, we took advantage of observations that upon 
binding peptide antigen, many (but not all; Lanzavecchia 
et al., 1992; Germain and Rinker, 1993; Nelson et al., 
1993) class II molecules become resistant to dissociation 
during SDS-PAGE conducted without sample boiling (Da- 
vidson et al., 1991; Germain and Hendrix, 1991; Sadegh- 
Nasseri and Germain, 1991). By analyzing unheated ver- 
sus boiled samples of anti-class II immunoprecipitates 
from gradient fractions obtained at various times after pro- 
tein labeling, we could evaluate the extent of peptide load- 
ing in a labeled class II cohort by observing the appearance 
of SDS-resistant (compact) class II dimers. In all the experi- 
ments, B cell blasts were fed with HEL, a complex protein 
that is efficiently internalized and processed into peptides 
that bind to AakApk, resulting in a marked enhancement in 
the appearance of SDS-stable compact dimers compared 
with cells cultured without added antigen (Germain and 
Hendrix, 1991). Of the class II molecules expressed by 
cells incubated in high concentrations of HEL, 30% or 
more are occupied with immunogenic fragments of this 
protein (Nelson et al., 1992). Thus, the compact dimer 
assay in this case allows sensitive detection of biologically 
relevant antigen loading without using T cell assays. 
Under these experimental conditions, after 20-30 min 
of chase, less than 1% of the total pool of MHC class II 
molecules was in the form of SDS-resistant compact di- 
mers (see Figure 8). This finding was concordant with the 
low level of Ii removal at this timepoint, as such removal 
is known to be necessary for stable peptide binding by 
class II molecules (Roche and Cresswell, 1990; Teyton et 
al., 1990; Romagnoli and Germain, 1994) and formation of 
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Figure 11. Trafficking of MHC Class II-Invariant Chain Complexes to 
the Endocytic Pathway via the Plasma Membrane/Early Endosomes 
(A and 8) Effect of DAB polymerization on the distribution of endocytic 
and Golgi markers in cells having internalized HRP for 10 min begin- 
ning 60 min after metabolic labeling began. The distributions of the 
endocytic marker f%hexosaminidase (open square), the late Golgi 
marker galactosyl transferase (closed diamond), and the TGN marker 
TGN36 (open circle) are shown in DAB-treated (A) and DAB-H20z- 
treated samples (8) from fractions of a 10% gradient. 
(C and El) Evidence that the class II and Ii present in peak 28 (light 
membranes) at 70 min after synthesis are largely associated with the 
plasma membrane, early endosomes, or both. Class II and associated 
invariant chain from the Peak 28 fractions of the gradients shown in 
(A) and (B) were immunoprecipitated using 10-2.16 and analyzed by 
compact dimers (Germain and Hendrix, 1991). The overall 
percentage of identifiable peptide-loaded class II dimers 
increased significantly with time, rising to 17% after 1 hr 
of chase (see Figure 8) 54% after 2 hr (see Figure lo), 
and 59% at 3 hr (data not shown). If HEL was omitted 
from the culture medium, only a small fraction of class II 
adopted the SDS-stable conformation, as previously re- 
ported (Germain and Hendrix, 1991) (data not shown). 
Thus, most of the SDS-stable dimers measured in these 
experiments contain exogenous antigen-derived pep- 
tides. 
The intracellular distribution of these antigen-occupied 
dimers, as well as the proportion of class II molecules in 
each compartment showing SDS stability, changed with 
time (see Figure 7). After 1 hr of chase, compact dimers 
were observed in all three peaks, with 15% of the total in 
intermediate density Peak 2A, and 50% in dense Peak 
1. These peptide-associated forms constituted only one 
seventh of the class II molecules in Peak 2A, whereas 
they accounted for 40% of the class II in dense Peak 1. 
After 2 hr, although less of the total compact dimer pool 
was in the intermediate density peak, such peptide-occupied 
molecules rose to 50% of the class II cohort still present 
here. In contrast, the proportion of class II in the compact 
form remained steady at 40% in the dense peak during 
an interval in which the total amount of class II in this 
compartment increased substantially. Very low levels of 
class II of any form remained in these two intracellular 
compartments at 3 hr. 
Previous reports have described a delay of 2-4 hr follow- 
ing Golgi transit in the expression of newly synthesized 
Ii-free class II molecules on the plasma membrane (Cress- 
well et al., 1987; Neefjes et al., 1990). At 2 hr of chase, 
compact dimers were increasingly localized to the lightest 
membrane fractions (see Figure 7; Figure lo), compatible 
with the expected progressive accumulation of peptide- 
loaded molecules on the plasma membrane and, at 3 hr, 
almost all of the labeled class II pool had reached the cell 
surface, the majority in the form of compact dimers. Thus, 
during their trafficking from TGN to plasma membrane, 
class II molecules occupied with peptides derived from 
active processing of an exogenous antigen source ap- 
peared in several endocytic compartments. The majority 
of these antigen-occupied dimers either accumulated, or 
were actively formed, in dense organelles colocalizing with 
lysosomal compartments. 
Discussion 
We have investigated in a physiological antigen-present- 
ing cell population the fate of a newly synthesized cohort 
of class II from the time of assembly with Ii in the ER to 
the time of expression of Ii-free peptide-loaded molecules 
on the plasma membrane. The data reveal a kinetically 
autoradiography. (C), DAB-treated fractions; (D), DAB-H,O&reated 
fractions. lmmunoprecipitation methods and labeling are as for 
Figure 5. 
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complex movement of class II and Ii into a number of 
clearly distinguishable endocytic organelles, and the ap- 
pearance of antigen-loaded class II molecules in multiple 
endocytic compartments. They do not support recent sug- 
gestions of a single unique compartment where class II 
accumulates and binds peptide (Amigorena et al., 1994; 
Tulp et al., 1994). 
Based on morphological observations, glycosylation 
studies, and surface labeling/carbohydrate modification 
experiments, several investigators have proposed that 
class II-Ii complexes traffic directly from the TGN to a 
class II-enriched cohort of late endosomesllysosomes, 
without passing through either the plasma membrane ol 
early endosomes (Lotteau et al., 1990; Neefjes et al., 1990; 
Peters et al., 1991). In contrast, studies with transferrin- 
neuraminidase conjugates (Cresswell, 1985), analysis of 
transfected cells coexpressing class II and Ii (Romagnoli 
et al., 1993), and internalization measurements (Roche et 
al., 1993) have suggested the opposite. There has been 
a similar debate over the route followed from their site of 
synthesis to their final location by other proteins concen- 
trated in dense endocytic compartments. Acid phospha- 
tase has been reported to transit the cell surface and the 
entire endocytic pathway before reaching lysosomes 
(Braun et al., 1989; Armstrong et al., 1990) or, alterna- 
tively, to move to lysosomes without any surface expres- 
sion (Mane et al., 1990). The MGPR-associated hydrolases 
were initially believed to traffic directly to late endosomes 
(Griffiths et al., 1988), but more recent studies show that 
at least 40%-500/o of cathepsin D passes through early 
endosomes (Ludwig et al., 1991). Some studies appear 
to exclude surface transit, or early endosomal passage, 
or both of lysosomal glycoproteins (Igps or lamps) (Harter 
and Mellman, 1992), while others provide evidence for 
such a route (Lippincott-Schwartz and Fambrough, 1987). 
Obtaining an answer to this trafficking question for class 
II molecules has been made difficult because of the sub- 
stantial underdetection of class II-Ii complexes compared 
with Ii-free class II molecules by many of the MAbs em- 
ployed in immunoprecipitation studies. The poor reactivity 
of these reagents with Ii-associated class II overempha- 
sizes the cohort of class II reaching later endocytic com- 
partments, where much of the interfering lumenal region 
of Ii is first removed from the complexes (Romagnoli et 
al., 1993; Romagnoli and Gerniain, 1994), enhancing anti- 
body binding. This change in serological reactivity is seen 
in metabolic labeling studies as a marked increase in over- 
all class II signal between the pulse-labeled sample and 
samples taken at l-2 hr of chase (for examples see Ger- 
main and Hendrix, 1991; Amigorena et al., 1994; Elliott 
et al., 1994; Tulp et al., 1994). In the present study, the 
1 O-2.18 MAb was specifically chosen because it quantita- 
tively reacts with both Ii-associated and Ii-free Ak class II 
molecules (Germain and Hendrix, 1991; R. N. G., unpub- 
lished data). 
Using this antibody for precipitation, newly synthesized 
MHC class II-Ii complexes were found in a light density 
fraction containing ER, Golgi, TGN, earlyendosomes, and 
plasma membrane following 40 min of metabolic labeling 
of activated B cells. This is in agreement with previous 
reports showing a lag period of 30-80 min for the ER as- 
sembly of MHC class II dimers on Ii trimer cores and the 
transit of these oligomers through the Golgi complex 
(Cresswell et al., 1987, 1990). At 80-70 min after synthe- 
sis, the majority of class II molecules were still found in 
the light density fractions of the gradient. DAB-induced 
density shift studies demonstrated that at this time at least 
50% of the labeled MHC class II and Ii was associated with 
fractions containing early endosomes, plasma membrane, 
or both, rather than TGN. Various endocytic tracers (oval- 
bumin and HRP) took less than 30 min in these B 
lymphoblasts to reach dense endocytic organelles. This 
high rate of transit through the endocytic subcompart- 
ments in these cells may explain why it has been difficult 
to define a timepoint at which, soon after their egress from 
the trans-Golgi network, afili complexes are exclusively in 
early endosomes or on the plasma membrane. Together, 
these findings imply that the measured figure of 50% is 
very likely to be a substantial underestimate of the real 
proportion of class II actually passing through this site. 
They clearly support a model of class II-Ii trafficking to 
the endocytic pathway in which a major route is from TGN 
to early endosomes (Romagnoli et al., 1993), possibly via 
the plasma membrane (Roche et al., 1993). The steady- 
state class II distribution observed here, with most class 
II on the cell surface or associated with intermediate or 
high density vesicles, agrees with the results of Peters et 
al. (1991), who, based on thisdistribution, suggested such 
a direct pathway from TGN to dense compartments. Much 
of the class II in such late endocytic organelles, however, 
seems to come from accumulation of molecules after rapid 
passage as class II-Ii complexes through light membrane 
fractions distinct from the TGN. Our inability to capture 
the entire cohort of class II in association with the plasma 
membrane or early endosomes leaves open the possibil- 
ity, however, that a fraction of class II accesses denser 
endocytic compartments directly from the TGN by an alter- 
native route. 
What is the fate of newly synthesized class II-Ii com- 
plexes after passage through the early endosomal com- 
partment, and where does antigen processing and binding 
to class II take place? In addition to early endosomes, 
class II molecules and intact Ii were also observed at early 
chase times in two distinct sets of denser organelles co- 
fractionating with what appear by protein marker and ki- 
netic tracer studies to be classical late endosomes and 
immature lysosomes. The rates of appearance and disap- 
pearance of class II and Ii, as well as the fraction of class 
II molecules showing evidence of peptide loading, were 
substantially different in these latter two locations, how- 
ever. In the fractions of intermediate density, total labeled 
class II and Ii reached a plateau between 20 and 80 min 
of chase, then decreased (Figure 9A). At both 1 and 2 
hr of chase, Ii-free compact (peptide-loaded) dimers were 
detected here along with the class II-Ii complexes, with 
the proportion, but not the absolute amount, of the peptide- 
occupied dimers increasing between these two timepoints 
(Figure 7). In contrast, total class II levels rose in dense 
Peak 1 between 20 and 80 min of chase, then remained 
steady until 2 hr (Figure 9A) and the amount, rather than 
Immunity 
84 
the proportion, of compact class II dimers also increased 
during this interval. In both compartments, there was a 
loss of intact class II-associated Ii (Figure 86) the appear- 
ance of Ii fragments, and a gain in compact dimers over 
time. These latter results, together with the presence of 
active proteases and the clear ability of exogenous pro- 
teins such as OVA to access these vesicles, suggests that 
antigen processing and binding to class II occurs in these 
organelles, rather than during very transient class II resi- 
dence elsewhere, followed by accumulation in Peaks 1 
and 2A. If this is correct, then the minimal requirements 
for antigen processing, MHC class II-peptide loading, or 
both must be shared by several distinct endocyticcompart- 
ments. 
The increase, then decrease in total class II and Ii, to- 
gether with the later overrepresentation of compact pep 
tide-loaded dimers in the intermediate density peak (Fig- 
ure 7) raise the possibility that the class II-Ii complexes 
entering this site may have two divergent fates. Some 
class II molecules that remain associated with Ii may move 
to the denser organelles of Peak 1, given the increase in 
class II and Ii in this latter compartment, while the amount 
in the intermediate peak declines. This possibility of selec- 
tive movement of Ii-associated class II from the Peak 2A 
organelles to denser endocytic compartments is consis- 
tent with the presence of intact Ii in Peak 1 organelles at 
later times, despite the more efficient removal of Ii from 
complexes once they reach this site (Figure 9B; Figure 
10). Another cohort of class II in the intermediate density 
organelle(s) may lose Ii there and acquire peptide, then 
move to the cell surface without trafficking to denser or- 
ganelles. 
At all the timepoints examined, a subset of dense organ- 
elles with the characteristics of immature lysosomes 
showed the greatest accumulation of peptide-loaded class 
II molecules. The use of HEL appears to emphasize the 
loading of peptide in the dense organelles at the expense 
of other processing compartments, particularly the inter- 
mediate compartment, although the presence of this anti- 
gen does not change the overall steady-state distribution 
of class II in the cell (unpublished data). This is fully consis- 
tent with the data of Collins et al. (1991) who found that 
disulfide reduction, a reaction associated with lysosomes, 
was essential for efficient processing of HEL for peptide 
binding to AakAPk molecules. These data in B cells are 
also in agreement with a recent study in which lysosome- 
associated fractions from mouse monocytes fed.with intact 
Listeria monocytogenes or exposed to HEL were found 
to contain MHC class II complexes capable of stimulating 
T cells in a presentation assay (Harding and Geuze, 1992, 
1993) with the data of West et al. (1994) looking at the 
site(s) of intracellular binding of labeled tetanus toxin to 
human class II molecules in B lymphoblastoid cells; Qiu 
et al. (1994) examining cytochrome c processing; Ruden- 
sky et al. (1994) examining binding of an endogenously 
generated Ea fragment; and an independent analysis of 
HEL processing in B cell tumor lines (J.-P. Gorval, per- 
sonal communication). The characteristics of this com- 
partment are entirely consistent with those of the MIIC 
compartment defined in human B lymphoblastoid cells 
largely by morphological studies. Our kinetic data suggest 
that the high density of class II in these organelles arises 
from accumulation of Ii- and peptide-associated molecules 
at this site prior to the exit of the latter to the plasma mem- 
brane. It remains to be shown explicitly that peptide- 
loaded class II molecules formed in this dense lysosome- 
related compartment actually contribute to the cell surface 
cohort available to T cells, although the lack of substantial 
class II degradation during a 3-4 hr chase period and the 
presence of up to 40% of labeled compact dimers in this 
site at 2 hr of chase strongly argue that this is the case. 
This would be consistent with reports of a bidirectional flow 
of membrane proteins between the plasma membrane and 
lysosome-related structures (Muller et al., 1983; Lippin- 
co&Schwartz and Fambrough, 1987; Jahraus et al., 1994). 
Because others have suggested, however, that peptide- 
occupied class II molecules in dense endocytic fractions 
may not traffic to the cell surface (Amigorena et al., 1994; 
West et al., 1994) further experiments are necessary to 
address this critical issue directly. 
In B cell blasts, both Ii chains p31 and p41 accompanied 
the a8 complexes to dense endocytic organelles. There 
was no evident change in the ratio of the two Ii species 
over time or in the various endocytic compartments, in 
contrast with speculation arising from functional studies 
on the p31 versus p41 forms of mouse Ii that implied that 
the p41 form would be more resistant to proteolysis and 
be overrepresented in highly acidic organelles (Peterson 
and Miller, 1992). During the transport along the endocytic 
pathway both forms of Ii are progressively degraded (Ro- 
magnoli et al., 1993; Marie et al., 1994) as revealed by 
the detection of Ii fragments after reimmunoprecipitation 
of samples with the anti-Ii tail-specific antibody IN-1 (data 
not shown). Despite this degradation, some intact Ii was 
associated with class II in dense peak 1 fractions, espe- 
cially at intermediate times of chase. This contrasts with 
prior studies of steady-state conditions showing little in- 
variant chain in this compartment (Peters et al., 1991) a 
difference that can be explained by the hypothesis that 
these Ii-containing class II complexes had just reached this 
site and were being detected prior to the rapid Ii proteolysis 
that occurs at this site. These results are in accord with 
the notion that class II trafficking to, and accumulation 
in, late endocyticllysosomal compartments may involve 
signals borne by the invariant chain (Bakke and Dob- 
berstein, 1990; Lotteau et al., 1990; Lamb et al., 1991; 
Romagnoli et al., 1993). 
Taken together, our resultssuggest the following model. 
A large fraction of newly synthesized MHC class II mole- 
cules together with associated invariant chain enter the 
endocytic pathway in an early light compartment and, to- 
gether with internalized antigens, they are transported 
through or accompany maturation of these organelles. As 
transit occurs from early endosomes, or for some mole- 
cules, possibly from the TGN, to compartments with many 
of the features of late endosomes or immature lysosomes, 
invariant chain is removed from the class II complexes 
with increasing efficiency. The denser more proteolytic 
compartments are also more proficient in degrading pro- 
tein antigen, but both the creation of available class II 
t5HC Class II Processing Pathway 
binding sites, as well as effective antigen processing, also 
occurs in earlier endocytic locations. When invariant chain 
is detached and class II molecules with empty binding 
sites are created, these molecules either interact with de- 
natured/partially degraded proteins or peptides, or they 
themselves undergo denaturation/chain dissociation (Ger- 
main and Rinker, 1993). Class II molecules successfully 
loaded with antigen leave the compartments in which they 
are formed, moving to the plasma membrane by an un- 
characterized route. 
The efficiency and quality of antigen processing in these 
different endocytic compartments will depend on the com- 
plexity of the protein to be degraded, its complement of 
protease recognition sites, and its requirements for un- 
folding prior to proteolysis (Sercarz et al., 1993) whereas 
the necessary dissociation of Ii from MHC class II will be 
influenced by both the hydrolytic activity of the endosomes 
and by the affinity of Ii for different class II alleles and 
isotypes (Germain and Rinker, 1993). The overall class II 
and Ii content of various compartments will also be af- 
fected by the rate of transfer between or maturation of the 
various endocytic organelles, events that may be regu- 
lated in a cell type-specific manner by small guanosine 
5’-triphosphate-binding proteins, trimeric G proteins, and 
other components of the vesicular transport system 
(Gruenberg and Clague, 1992) as well as by Ii itself (Ro- 
magnoli et al., 1993). The class II-related dimer DM has 
also very recently been found to participate in the class II 
processing/presentation pathway, possibly by facilitating 
the removal of the fragment of Ii regulating the function 
of the class II binding site (Morris et al., 1994; Fling et al., 
1994). Its distribution among these organelles may affect 
the nature of the determinants captured by class II at each 
site, as might the content of other possible “chaperone” 
molecules (Cristau et al., 1994). 
Our findings and this interpretation differ from those of 
several recent studies, which concluded that Ii-removal, 
antigen processing, and peptide binding to class II may 
all take place in a single novel endocytic subcompartment 
(Amigorenaet al., 1994; Tulp et al., 1994; Rudensky et al., 
1994). Yet the several studies reaching such a conclusion 
reported different marker profiles for the relevant compart- 
ment, as well as different kinetics for endocytic tracer ac- 
cess to this putative specialized class II compartment, rais- 
ing questionsabout whetherthe sameorganelle was being 
studied in each case. In addition, none of these studies 
clearly identified the early sites of class II-Ii complex local- 
ization in the endocytic compartment, leaving open the 
question of whether the results being reported reflected 
only the late behavior of class II after much of the associ- 
ated Ii had been released and, perhaps, antigen already 
bound. Finally, these experiments all used transformed 
clonal cell lines whose properties may or may not fully 
reflect those of physiological antigen-presenting cell popu- 
lations. The present studies employed normal B lympho- 
blasts to avoid this latter problem and, as indicated earlier, 
used antibody reagents that permitted complete tracking 
of all class II molecules from the time prior to Ii dissociation 
to late expression of peptide-occupied molecules on the 
plasma membrane. The relative distribution of class II in 
the fractions of each peak at all times paralleled the distri- 
bution of the P-hexosaminidase marker, the organelle- 
specific markers (transferrin, Cl-MGPR, lamp-l), and the 
bulk of endocytosed protein tracers such as OVA. The 
most straightforward interpretation of these colocalization 
data is that class II (and Ii) actually traffic to and carry out 
their functions in classically defined early endosomes, late 
endosomes, and immature lysosomes, although such or- 
ganelles may differ in some of their properties from those 
characteristic of moretypically studied fibroblasts and epi- 
thelial cells. It is possible, however, that the class Il-con- 
taining endocytic structures identified here merely share 
the same densities as the classical organelles and, hence, 
comigrate in the Percoll gradients. Experiments are ongo- 
ing to determine whether additional fractionation methods, 
such as those based on charge, will segregate the various 
class II-containing vesicles from the classically defined 
endocytic organelles present in the same Percoll fractions. 
Even if this should prove to be the case, it remains clear 
from the present results that class II accesses more than 
one such endocytic compartment, and that antigen-con- 
taining class II dimers appear in more than one of these 
sites prior to their expression on the plasma membrane. 
Some antigenic determinants available to class II in an 
early endocytic compartment might be degraded and lost 
before reaching and binding to class II molecules in a late 
endosome- or lysosome-like compartment. Likewise, for 
some proteins, the denaturing and proteolytic environ- 
ment of the latter will be required to reveal more hidden 
antigenic epitopes, and class II molecules with unoccu- 
pied binding sites must also be made available in this loca- 
tion to capture this important antigen cohort. The capacity 
to acquire ligands in different endocytic subcompartments 
and then exit to the plasma membrane would ensure the 
potential access of MHC class II to multiple determinants 
in proteins of varying structural characteristics, helping to 
maximize the capacity of the immune system to recog- 
nize the presence of an invading organism or its secreted 
products. 
Expertmental Procedures 
Cell8 
Single cell suspensions from the spleens of CBA/J. (H-2k) mice were 
depleted of erythrocytes by lysis in ACK buffer (Biofluids). Cells were 
incubated for 2 hr at 37OC in complete culture medium (RPM plus 
10% fetal calf serum) in tissue culture-grade petri dishes (Costar) to 
remove adherent cells (primarily macrophages and dendritic cells). 
Nonadherent cells were collected and cultured in complete medium 
in the presence of 10 ug/ml Escherichia coli lipopolysaccharide 
(Sigma) for45 hr. The resulting population, enriched in 6 lymphoblasts 
(70%-W% positive for MHC class II and 9220; l%-2% positive for 
Mac-l) was used for all labeling and fractionation studies. 
Cell Labeling and Fractionation 
Ceils (300 x IV in 50 ml) were cultured at 37OC for 1 hr in medium 
lacking leucine (GIBCO RPM1 media kit), pulsed with PH]leucine (New 
England Nucleotides, 163 CilmMol) at 0.5 mCi per ml for 40 min, and 
chased at 37W in the presence of IO x cold leucine for increasing 
periods of time (20 min to 3 hr). During the prelabeling, labeling, and 
chase periods, the B cell blasts were cultured in the presence of 2 
mglml HEL (Sigma) as a source of antigen known to give rise to pep 
tides binding to AahApk molecules. Cells were disrupted by nitrogen 
cavitation in 5 ml of homogenizing buffer (1 x = 0.25 M Sucrose, 1 
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mM EDTA [pH 6.61). Postnuclear supernatant was prepared by low 
speed centrifugation (1,000 x g for 5 min at 4OC). of Percoll, 25 ml 
(27%), prepared as previously described (Robbins and Roff, 1967), 
was layered onto a cushion of 5 ml of 2.5 M sucrose. Postnuclear 
supernatant (5 ml) was layered onto the Percoll and centrifugation 
carried out in a VTiW vertical rotor (Beckman Instruments, Palo Alto, 
California) for 1 hr at 34,500 x g at 4OC. Fractions of 1 ml were 
collected from the bottom of the gradient using a Beckman fraction 
recovery system. Fractions comprising the light peak of p-hexosamini- 
dase activity were pooled and refractionated on a 10% Percoll gradient 
using the same methods. 
Marker Analysis 
The marker enzymes Q-hexosaminidase (characteristic of endocytic 
pathwayorganelles, especially lysosomes; Mane et al., 1969) and ga- 
lactosyl transferase (trans-Golgi; Roth and Berger, 1962) were as- 
sayed bypublishedprocedures(Romeetal., 1979; Greenetal.. 1967). 
BIP (ER; Munro and Pelham, 1986), Na+ K+ ATPase (plasma mem- 
brane; Vasilets and Schwarz, 1993), lamp1 (Iysosomes; Mane et al., 
1989), TGN38 (Luzio et al., 1990) , cathepsin B and D (endosomes/ 
lysosomes; Blum et al., 1991). transferrin (early endosomes; Dautry- 
Varsat. 1986), the cation-independent mannose bphosphate receptor 
(Cl-MGPR) (TGN and late endosomes; Kornfeld. 1992), internalized 
ovalbumin (kinetically defined endocytic organelles), and surface 
bound anti-MHC class II antibodies (plasma membrane) were assayed 
by dot blot using 100 ~1 of each fraction, the appropriate primary anti- 
body, and secondary antibodies (Jackson Laboratories) conjugated 
to alkaline phosphatase. 5bromo4chlorc&indol~~-phosphatelni- 
troblue tetrazolium (BCIP). was used as a calorimetric substrate. For 
labeling of transferrin-containing compartments, cells were incubated 
with human transferrin (iron saturated, Boehringer) at 20 vg/ml for 20 
min ‘at 37OC. For labeling of the plasma membrane, 10% of the total 
cell population was incubated for 30 min at 4OC with the anti-Agk- 
specific MAb 1 O-2.16. Cells were extensively washed and pooled with 
the remaining 90% of the cells before being disrupted for subcellular 
fractionation. This method of plasma membrane identification gave 
identical results to those obtained using Na+ K+ ATPase, a classical 
plasma membrane marker. To determine the rate at which endocy- 
tosed material accessed various organelles, B lymphoblasts were cul- 
tured at 37OC with 3 mg/ml ovalbumin (Sigma) for increasing periods 
of time prior to washing, disruption, and density separation. 
The anti-lamp-l MAb lD4B (Chen et al., 1985) was a gift of J. T. 
August, John Hopkins University, Baltimore, Maryland,; the anti- 
TGN38 antiserum was a gift from J. Bonifacino, National Institute of 
Child Health and Human Development, National Institutes of Health; 
the hamster antiserum to the cation-independent MBPR was a gift from 
A. Robbins, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health; and the anti-transferrin and 
anticathepsin antisera was from Serotec. The anti-BIP and the anti- 
Na+ K+ ATPase antibodies were purchased from Affinity Bioreagents. 
The anti-ovalbumin MAb was produced in this laboratory using stan- 
dard methods (R. N. G., unpublished data). 
DAB Depletion ot Early Endoaomes 
A HRP-dependent shift in organelle density was produced using the 
procedure of Courtoy et al. (1964). 3,3,- diaminobenzidine tetrahydro- 
chloride was dissolved at a concentration of 4 mg/ml in homogenizing 
buffer 1 x , the pH adjusted to 7.0, and the solution cleared by filtration 
through a0.2 pm filter. Lipopolysaccharide-cultured spleen cells were 
incubated for 10 min in 2 mglml of horseradish peroxidase at 37X, 
then washed extensively, disrupted, and run on a 27% Percoll gradi- 
ent. After the first gradient was collected, each fraction corresponding 
to the light 6-hexosaminidase peak was divided in two and one aliquot 
treated with diaminobenzidine (final concentration, 2 mg/ml) and 6 pl 
of 6% HZ02. As a control, the other half of the fraction was treated 
with DAB without the addition of H202. The reactions were incubated 
for 30 min in the dark at room temperature with gentle agitation. The 
treated and mock-treated samples were then separately pooled and 
applied to two 10% Percoll gradients. Fractions were then collected 
and processed for immunoprecipitation as described below. 
Immunopreclpitation and Western Blot Analysis 
Membrane-associated material in gradient fractions was solubilized 
using standard lysis buffer containing 2% NP-40 (Germain and Hendrix, 
1991). Percoll was removed by high speed centrifugation (100,000 x 
g for 30 min) and MHC class II molecules were immunoprecipitated 
with theMAb lo-2.16(0ietal., 1978)prebound toproteinA-Sepharose 
beads (Germain and Hendrix, 1991). Samples from individual immuno- 
precipitates were divided into two aliquots and eluted in SDS buffer 
containing 2 6-mercaptoethanol, either under partial denaturing condi- 
tions (without sample boiling) or with boiling. The eluted samples were 
analyzed by SDS-PAGE using 10% polyacrylamide gels. Gels were 
fixed, treated with En3 Hance (Amersham), dried, and exposed to 
Kodak XAR-5 film at -7OOC. 
For analysis of total MHC class II content, fractions obtained from 
unlabeled cells were solubilized, immunoprecipitated, and subjected 
to SDS-PAGE as described above. The contents of the gel were then 
transferred to nitrocellulose and the MHC class II chains identified 
using rabbit antisera specific for the cytoplasmic tail of Aa (Sant et 
al., 1991), followed by mouse anti-rabbit antibody conjugated to HRP, 
and detection by enhanced chemiluminescence (Amersham). 
Dentltometry 
The dot blots, autoradiographs, or chemiluminescence film exposures 
were analyzed using a Molecular Dynamics Scanning Densitometer 
and the software provided by the manufacturer. Values for total class 
II, totalcompactdimer, ortotal Ii wereobtained bysumming therespec- 
tive signals from all gradient fractions. The signal for class II. compact 
dimer, or Ii in a set of fractions corresponding to a 6-hexosaminidase 
peak was also measured and used to calculate the proportion of that 
species in the peak relative to the total amount of a particular species 
in the entire gradient or an individual peak. Comparison of the 6-hexos- 
aminidass content of the total light peak pool from the first 27% gradi- 
ent and the fractions collected from the 10% gradient indicated that 
-90% of the signal was recovered jn the second gradient. This num- 
ber was used to correct the actu?l densitometer values for class II in 
the intermediate and light peaks resolved Iti the second gradient, so 
that class II content of fratiibns derived from both 27% and 10% 
gradients could be directly compared. 
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